UK doubles statutory payment rate on pharmaceutical sales from July The UK government has doubled the rate that pharmaceutical companies must repay on the sales of newer products to the NHS under the statutory scheme for branded medicines in the second half of 2025, t...

#ABPI #spendingreview #StatutoryScheme #VoluntaryScheme #VPAG #pharmaceuticalsales #UKgovernment #pharmaceuticalcompanies #NHS #brandedmedicines #NHSsales #healthcarebudget #healthcarespending #pharmaindustryinvestment #UK #VPAGreview #lifescienceinvestments
www.abpi.org.uk/media/news/2...